Sweet syndrome in a patient receiving encorafenib and binimetinib therapy for malignant melanoma
Myiah Quach, BS,
John P. Antonelli, BS,
Charlotte LaSenna, MD,
Mackenzie Asel, MD,
Jennifer Pleva, DNP,
Vincent T. Ma, MD
Affiliations
Myiah Quach, BS
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
John P. Antonelli, BS
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Charlotte LaSenna, MD
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Department of Dermatology, University of Wisconsin–Madison, Madison, Wisconsin
Mackenzie Asel, MD
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Department of Dermatology, University of Wisconsin–Madison, Madison, Wisconsin
Jennifer Pleva, DNP
UW Health, Madison, Wisconsin
Vincent T. Ma, MD
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Department of Dermatology, University of Wisconsin–Madison, Madison, Wisconsin; Division of Hematology, Medical Oncology and Palliative Care, Department of Medicine, University of Wisconsin–Madison, Madison, Wisconsin; Correspondence to: Vincent T. Ma, MD, Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, Carbone Cancer Center, University of Wisconsin, 600 Highland Ave, K4/550, Madison, WI 53705-2275.
